摘要 |
<p>The present invention relates to the use of a natriurectic peptide, such as urodilatin, for treating a patient suffering from heart failure, such as acute decompensated heart failure. Preferably, a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously through a time period of at least 24 hours and up to 120 hours, preferably at least 48 hours.</p> |
申请人 |
CARDIOPEP PHARMA GMBH;MITROVIC, VESELIN;LUSS, HARTMUT;FORSSMANN, WOLF-GEORG;MEYER, MARKUS;DOHLER, KLAUS |
发明人 |
MITROVIC, VESELIN;LUSS, HARTMUT;FORSSMANN, WOLF-GEORG;MEYER, MARKUS;DOHLER, KLAUS |